Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer

Yu Sunakawa, Yasutoshi Kuboki, Jun Watanabe, Tetsuji Terazawa, Hisato Kawakami, Mitsuru Yokota, Masato Nakamura, Masahito Kotaka, Naotoshi Sugimoto, Hitoshi Ojima, Eiji Oki, Takeshi Kajiwara, Yoshiyuki Yamamoto, Yasushi Tsuji, Tadamichi Denda, Takao Tamura, Soichiro Ishihara, Hiroya Taniguchi, Takako Eguchi Nakajima, Satoshi Morita, Kuniaki Shirao, Naruhito Takenaka, Daisuke Ozawa, Takayuki Yoshino

Open source

DOI: 10.1007/s11523-023-01027-8
Published: 2024-01
Container: Targeted Oncology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s11523-023-01027-8,
  title = {Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer},
  author = {Yu Sunakawa and Yasutoshi Kuboki and Jun Watanabe and Tetsuji Terazawa and Hisato Kawakami and Mitsuru Yokota and Masato Nakamura and Masahito Kotaka and Naotoshi Sugimoto and Hitoshi Ojima and Eiji Oki and Takeshi Kajiwara and Yoshiyuki Yamamoto and Yasushi Tsuji and Tadamichi Denda and Takao Tamura and Soichiro Ishihara and Hiroya Taniguchi and Takako Eguchi Nakajima and Satoshi Morita and Kuniaki Shirao and Naruhito Takenaka and Daisuke Ozawa and Takayuki Yoshino},
  year = {2024},
  journal = {Targeted Oncology},
  doi = {10.1007/s11523-023-01027-8},
  url = {https://doi.org/10.1007/s11523-023-01027-8}
}

RIS

TY  - JOUR
TI  - Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer
AU  - Yu Sunakawa
AU  - Yasutoshi Kuboki
AU  - Jun Watanabe
AU  - Tetsuji Terazawa
AU  - Hisato Kawakami
AU  - Mitsuru Yokota
AU  - Masato Nakamura
AU  - Masahito Kotaka
AU  - Naotoshi Sugimoto
AU  - Hitoshi Ojima
AU  - Eiji Oki
AU  - Takeshi Kajiwara
AU  - Yoshiyuki Yamamoto
AU  - Yasushi Tsuji
AU  - Tadamichi Denda
AU  - Takao Tamura
AU  - Soichiro Ishihara
AU  - Hiroya Taniguchi
AU  - Takako Eguchi Nakajima
AU  - Satoshi Morita
AU  - Kuniaki Shirao
AU  - Naruhito Takenaka
AU  - Daisuke Ozawa
AU  - Takayuki Yoshino
PY  - 2024
JO  - Targeted Oncology
DO  - 10.1007/s11523-023-01027-8
UR  - https://doi.org/10.1007/s11523-023-01027-8
ER  -

APA

Sunakawa, Y., Kuboki, Y., Watanabe, J., Terazawa, T., Kawakami, H., Yokota, M., Nakamura, M., Kotaka, M., Sugimoto, N., Ojima, H., Oki, E., Kajiwara, T., Yamamoto, Y., Tsuji, Y., Denda, T., Tamura, T., Ishihara, S., Taniguchi, H., Nakajima, T. E., Morita, S., Shirao, K., Takenaka, N., Ozawa, D., & Yoshino, T. (2024). Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer. Targeted Oncology. https://doi.org/10.1007/s11523-023-01027-8

Source records

crossref · retrieved 2026-09-27T10:13:17.893Z